Keyphrases
T Cells
100%
Natural Killer Cells
100%
Reconstitution
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
71%
Umbilical Cord Blood
42%
Immune Reconstitution
28%
HLA-matched Donor
28%
HSCT Recipient
28%
Graft-versus-host Disease (GvHD)
14%
Tumor Targeting
14%
Healthy Individuals
14%
Epidermis
14%
Tumor Response
14%
Interleukin-15 (IL-15)
14%
Cell-to-cell
14%
T Cell Repertoire
14%
T Cell Response
14%
Cell-mediated
14%
Tumor-infiltrating Lymphocytes
14%
Early Relapse
14%
Low Toxicity
14%
Natural Killer T
14%
Stem Cell Source
14%
Treatment Failure
14%
Major Histocompatibility
14%
Multiple Strategies
14%
CMV Reactivation
14%
TIGIT
14%
Tumor Immunosurveillance
14%
Individual Recipients
14%
Anti-tumor Response
14%
Inhibitory Molecules
14%
Total Leukocytes
14%
Immunology and Microbiology
Natural Killer Cell
100%
T Cell
100%
Immunotherapy
100%
Allogeneic Hematopoietic Stem Cell Transplantation
55%
Umbilical Cord Blood
33%
Immune Reconstitution
22%
Graft-Versus-Host Disease
11%
Immunosurveillance
11%
Histocompatibility
11%
Intravenous Immunoglobulin
11%
Stem Cell
11%
Tumor-Infiltrating Lymphocytes
11%
Interleukin 15
11%
Immunology
11%
Lymphocyte
11%